Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Cleavage of the leptin receptor by matrix metalloproteinase-2 promotes leptin resistance and obesity in mice.

Mazor R, Friedmann-Morvinski D, Alsaigh T, Kleifeld O, Kistler EB, Rousso-Noori L, Huang C, Li JB, Verma IM, Schmid-Schönbein GW.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaah6324. doi: 10.1126/scitranslmed.aah6324.

PMID:
30135249
2.

Isoform-specific subcellular localization and function of protein kinase A identified by mosaic imaging of mouse brain.

Ilouz R, Lev-Ram V, Bushong EA, Stiles TL, Friedmann-Morvinski D, Douglas C, Goldberg JL, Ellisman MH, Taylor SS.

Elife. 2017 Jan 12;6. pii: e17681. doi: 10.7554/eLife.17681.

3.

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.

Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH.

Oncotarget. 2016 Feb 16;7(7):7403-14. doi: 10.18632/oncotarget.7232.

4.

Targeting NF-κB in glioblastoma: A therapeutic approach.

Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma IM.

Sci Adv. 2016 Jan 8;2(1):e1501292. doi: 10.1126/sciadv.1501292. eCollection 2016 Jan.

5.

Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction.

Ben-Gedalya T, Moll L, Bejerano-Sagie M, Frere S, Cabral WA, Friedmann-Morvinski D, Slutsky I, Burstyn-Cohen T, Marini JC, Cohen E.

EMBO J. 2015 Nov 12;34(22):2820-39. doi: 10.15252/embj.201592042. Epub 2015 Oct 5.

6.

Identification of therapeutic targets for glioblastoma by network analysis.

Friedmann-Morvinski D, Bhargava V, Gupta S, Verma IM, Subramaniam S.

Oncogene. 2016 Feb 4;35(5):608-20. doi: 10.1038/onc.2015.119. Epub 2015 May 11.

7.

Glioblastoma heterogeneity and cancer cell plasticity.

Friedmann-Morvinski D.

Crit Rev Oncog. 2014;19(5):327-36. Review.

PMID:
25404148
8.

Dedifferentiation and reprogramming: origins of cancer stem cells.

Friedmann-Morvinski D, Verma IM.

EMBO Rep. 2014 Mar;15(3):244-53. doi: 10.1002/embr.201338254. Epub 2014 Feb 14. Review.

9.

Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.

Agemy L, Kotamraju VR, Friedmann-Morvinski D, Sharma S, Sugahara KN, Ruoslahti E.

Mol Ther. 2013 Dec;21(12):2195-204. doi: 10.1038/mt.2013.191. Epub 2013 Aug 20. Erratum in: Mol Ther. 2014 Nov;22(11):2013.

10.

Overexpression Models: Lentiviral Modeling of Brain Cancer.

Friedmann-Morvinski D, Singer O.

Curr Protoc Mouse Biol. 2013 Jun 1;3(2):121-39. doi: 10.1002/9780470942390.mo110271.

PMID:
26069061
11.

Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman E, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, Lasorella A.

J Clin Invest. 2013 Jan;123(1):405-17. doi: 10.1172/JCI63811. Epub 2012 Dec 17. Erratum in: J Clin Invest. 2014 Sep 2;124(9):4134.

12.

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM.

Science. 2012 Nov 23;338(6110):1080-4. doi: 10.1126/science.1226929. Epub 2012 Oct 18.

13.

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma.

Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17450-5. doi: 10.1073/pnas.1114518108. Epub 2011 Oct 3. Erratum in: Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11906.

14.

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.

Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma IM, Kosik KS.

Oncogene. 2012 Apr 12;31(15):1884-95. doi: 10.1038/onc.2011.380. Epub 2011 Aug 29.

15.

Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, Nawaz Z, Prasanna KV, Thennarasu K, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V, Somasundaram K.

J Biol Chem. 2011 Jul 22;286(29):25882-90. doi: 10.1074/jbc.M110.178012. Epub 2011 May 25.

16.

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

Padler-Karavani V, Hurtado-Ziola N, Pu M, Yu H, Huang S, Muthana S, Chokhawala HA, Cao H, Secrest P, Friedmann-Morvinski D, Singer O, Ghaderi D, Verma IM, Liu YT, Messer K, Chen X, Varki A, Schwab R.

Cancer Res. 2011 May 1;71(9):3352-63. doi: 10.1158/0008-5472.CAN-10-4102. Epub 2011 Apr 19.

17.

Transdifferentiation of glioblastoma cells into vascular endothelial cells.

Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4274-80. doi: 10.1073/pnas.1016030108. Epub 2011 Jan 24.

18.

Development of a novel mouse glioma model using lentiviral vectors.

Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, Gage FH, Verma IM.

Nat Med. 2009 Jan;15(1):110-6. doi: 10.1038/nm.1863. Epub 2009 Jan 4.

19.

Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation.

Friedmann-Morvinski D, Bendavid A, Waks T, Schindler D, Eshhar Z.

Blood. 2005 Apr 15;105(8):3087-93. Epub 2004 Dec 30.

20.

Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis.

Harrus S, Waner T, Friedmann-Morvinski D, Fishman Z, Bark H, Harmelin A.

Vet Immunol Immunopathol. 2003 Dec 15;96(3-4):239-43.

PMID:
14592737
21.

Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice.

Harmelin A, Pinthus JH, Friedmann-Morvinski D, Kaufman K, Brenner O.

Vet Immunol Immunopathol. 2002 Jul;86(3-4):245-9.

PMID:
12007890

Supplemental Content

Loading ...
Support Center